Skip to content
Disclosery

GTCR LLC

Follow

13F filer, CIK 1576350, CHICAGO, IL

GTCR LLC reported $3,906,824,589 across 5 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-26-032840

Period
2026-06-30
Reported value
$3.91B
Holdings
5
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SHCexited-12,735,301-$183M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001140361-26-032840, largest first. % of portfolio is the value over $3,906,824,589, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GPNGLOBAL PMTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,268,041 shares; 2026Q2: 43,268,041 shares 43,268,041$3.14B80.36%0Timeline
AJGGALLAGHER ARTHUR J & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,373,773 shares; 2026Q2: 2,373,773 shares 2,373,773$545M13.95%0Timeline
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 20,150,005 shares; 2024Q4: 20,150,005 shares; 2025Q1: 20,150,005 shares; 2025Q2: 20,150,005 shares; 2025Q3: 20,150,005 shares; 2025Q4: 20,150,005 shares; 2026Q1: 20,150,005 shares; 2026Q2: 20,150,005 shares 20,150,005$126M3.22%0Timeline
GOGOGOGO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 31,739,011 shares; 2024Q4: 31,739,011 shares; 2025Q1: 31,739,011 shares; 2025Q2: 23,239,011 shares; 2025Q3: 23,239,011 shares; 2025Q4: 23,239,011 shares; 2026Q1: 23,239,011 shares; 2026Q2: 23,239,011 shares 23,239,011$72M1.84%0Timeline
SEATVIVID SEATS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,768,633 shares; 2026Q1: 3,768,633 shares; 2026Q2: 3,768,633 shares 3,768,633$24.6M0.63%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SHCSOTERA HEALTH CO12,735,301$183Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001140361-26-032840 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001140361-26-032840 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001140361-26-021509 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001140361-26-005753 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001140361-25-041971 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001140361-25-031205 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001140361-25-018824 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001140361-25-004669 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001140361-24-046487 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR/A 0001140361-24-037071 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001140361-24-036665 Quarter ended 2024-06-302024-08-09acceptance time not in the bulk data set
13F-HR 0001140361-24-025844 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001140361-24-007603 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001140361-23-052683 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001140361-23-039252 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0001140361-23-024371 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001140361-23-002829 Quarter ended 2022-12-312023-01-26acceptance time not in the bulk data set
13F-HR/A 0001140361-22-041672 Quarter ended 2022-09-302022-11-15acceptance time not in the bulk data set
13F-HR 0001140361-22-040627 Quarter ended 2022-09-302022-11-09acceptance time not in the bulk data set
13F-HR 0001567619-22-014153 Quarter ended 2022-06-302022-07-19acceptance time not in the bulk data set
13F-HR 0001567619-22-009904 Quarter ended 2022-03-312022-05-10acceptance time not in the bulk data set
13F-HR 0001567619-22-003653 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001567619-21-019040 Quarter ended 2021-09-302021-11-01acceptance time not in the bulk data set
13F-HR 0001567619-21-014484 Quarter ended 2021-06-302021-08-05acceptance time not in the bulk data set
13F-HR 0001567619-21-010549 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001567619-21-004098 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set